Biocryst Pharmaceuticals (BCRX) EPS (Diluted) Growth (3y) (2016 - 2026)
Biocryst Pharmaceuticals (BCRX) EPS (Diluted) Growth (3y) (2016 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 44.07 Bn | 43.10 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.41 Bn | 39.75 Bn | 2.15 Bn | 15.17% |
| 3 | Zoetis | 31.83 Bn | 30.15 Bn | 1.05 Bn | 3.25% |
| 4 | Takeda Pharmaceutical | 28.77 Bn | 22.97 Bn | 5.10 Bn | 2.66% |
| 5 | United Therapeutics | 22.27 Bn | 19.61 Bn | 683.80 Mn | 11.56% |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | -35.09% |
| 7 | Neurocrine Biosciences | 15.65 Bn | 15.26 Bn | 935.80 Mn | 13.29% |
| 8 | Elanco Animal Health | 11.93 Bn | 11.40 Bn | 798.00 Mn | 36.48% |
| 9 | Dr Reddys Laboratories | 10.16 Bn | 10.00 Bn | - | - |
| 10 | Biocryst Pharmaceuticals | 2.47 Bn | 2.12 Bn | 214.41 Mn | 39.97% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 39.97% |
| Mar 31, 2026 | -119.19% |
| Dec 31, 2025 | 70.11% |
| Sep 30, 2025 | 31.17% |
| Jun 30, 2025 | 27.51% |
| Mar 31, 2025 | 26.00% |
| Dec 31, 2024 | -9.31% |
| Sep 30, 2024 | 94.09% |
| Jun 30, 2024 | 93.67% |
| Mar 31, 2024 | 22.05% |
| Dec 31, 2023 | 7.07% |
| Sep 30, 2023 | 9.97% |
| Jun 30, 2023 | 88.15% |
| Mar 31, 2023 | -5.09% |
| Dec 31, 2022 | -140.02% |
| Sep 30, 2022 | 12.58% |
| Jun 30, 2022 | 2.20% |
| Mar 31, 2022 | -12.01% |
| Dec 31, 2021 | 25.98% |
| Sep 30, 2021 | -946.12% |